Bio-Perspectives SRL
Bio-Perspectives reported total assets of 206,760 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026).
The score of Bio-Perspectives shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bio-Perspectives's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
Bio-Perspectives's financial analysis
- Solvency81.3%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bio-Perspectives
Bio-Perspectives's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1000.325.168
- VAT number
- BE1000325168
- Peppol
- Registered · 0208:1000325168 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2023
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Bio-Perspectives (SRL) has been based in Ixelles since 2023, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 79,613 € and equity of 168,178 €; its revenue is not published. Its solvency stands at 81.3%, above the median of its sector (45.7%).
Companies similar to Bio-Perspectives
Companies in the same business, of comparable size and area, outside its group.
- Opero Research and experimental development on natural sciences and engineering Grimbergen · balance sheet 225,981 €
- Thalen Biotech Consultancy Research and experimental development on natural sciences and engineering Frasnes-lez-Anvaing · balance sheet 215,550 €
- Clino Consult Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 191,749 €
- ProteoFormiX Research and experimental development on natural sciences and engineering Vorselaar · balance sheet 182,817 €
- Perpetuum CropScience Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 181,346 €
- EDF Quality Services Research and experimental development on natural sciences and engineering Zoersel · balance sheet 313,863 €
- CBaBC Research and experimental development on natural sciences and engineering Destelbergen · balance sheet 249,523 €
- Thomas De Beer Consulting Research and experimental development on natural sciences and engineering Deinze · balance sheet 252,275 €
Frequently asked questions about Bio-Perspectives
What is the revenue of Bio-Perspectives?
Bio-Perspectives files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bio-Perspectives?
In Belgium, the VAT number is the company number prefixed with BE: BE1000325168 for Bio-Perspectives, if the company is VAT-registered. Its company number (CBE) is 1000.325.168.
Where is the registered office of Bio-Perspectives?
According to the CBE register, the registered office of Bio-Perspectives is in 1050 Ixelles.
What is the equity of Bio-Perspectives?
At the close of the 2025 financial year, the equity of Bio-Perspectives amounts to 168,178 €, a solvency of 81.3% of total assets.
Who manages Bio-Perspectives?
The register lists 1 active mandates at Bio-Perspectives. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bio-Perspectives
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →